Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The scientific aim of this study is to investigate the efficacy of abobotulinumtoxinA
(Dysport - Ipsen Pharmaceuticals) in chronic low back pain.
The investigators hypothesis is that injection of Dysport brand of botulinum toxin type A
into erector spinae muscles (extensors of the spine) can relieve low back pain through
anti-spasm and analgesic effect of botulinum toxin.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA